NCT00570245View on ClinicalTrials.gov

Safety and Efficacy Study of Nitric Oxide in Patients Going Through Lung Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Lung Transplantation
Interventions
DRUG

Nitric oxide

inhalation, 10 ppm, for up to 48 hours

DRUG

Nitric oxide

inhalation; 10ppm; 3 hours (donor) up to 48 hours (recipient)

Trial Locations (1)

46009

Hospital General La Fe, Valencia

Sponsors

Lead Sponsor

Mallinckrodt
All Listed Sponsors
lead

Mallinckrodt

INDUSTRY

NCT00570245 - Safety and Efficacy Study of Nitric Oxide in Patients Going Through Lung Transplantation | Biotech Hunter | Biotech Hunter